Mindfulness-Based Health Promotion Program for Educators (MBHP - Educa).
NCT03839030, Not applicable, Completed, Marcelo Demarzo, MD, PhD
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Mindfulness-Based Health Promotion Program for Educators (MBHP - Educa). | ClinicalTrials.gov |
| NCT number | NCT03839030 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 146 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Marcelo Demarzo, MD, PhD | ClinicalTrials.gov |
| Conditions | Stress, Cognitive Impairment, Burnout Syndrome | ClinicalTrials.gov |
| Interventions | MBHP-Educa | ClinicalTrials.gov |
| First posted | 2019-02-12 | ClinicalTrials.gov |
| Last updated | 2021-03-03 | ClinicalTrials.gov |
Registered outcomes 15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | World Health Organization Quality of Life-BREF (WHOQOL-BREF) | Pre-test, Post-test and follow-up (12 months) | To evaluate quality of life through five subscales: physical domain - mean of responses psychological domain - mean of responses relationships domain - mean of responses environment domain - mean of responses quality of life and perception of life - mean of responses \*each question response range one to five points Higher scores - Better Quality of Life | ClinicalTrials.gov |
| Primary | Pittsburgh Sleep Quality Index | Pre-test, Post-test and follow-up (12 months) | To evaluate the Sleep Quality - sum of responses score \*each questions have a specific conversion to range zero to six Higher scores - better sleep quality | ClinicalTrials.gov |
| Primary | Morningness-eveningness questionnaire - sum *Range 16 to 86 *higher scorer - more morningness type | Pre-test, Post-test and follow-up (12 months) | To evaluate person's circadian rhythm (biological clock) (sum of all responses) | ClinicalTrials.gov |
| Secondary | Glutathione metabolism from blood samples | Pre-test, Post-test and follow-up (12 months) | GSH plasma levels, Cysteine and homocisteine serum levels | ClinicalTrials.gov |
| Secondary | Perceived Stress Scale (PSS-10) | Pre-test, Post-test and follow-up (12 months) | to evaluate the level of subjectively noticed stress, composed of 10 items | ClinicalTrials.gov |
| Secondary | Determination of cytokine levels in serum samples. | Pre-test, Post-test and follow-up (12 months) | To evaluate the interleukin-8 (IL-8), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10), tumor necrosis factor (TNF) e interleukin-12p70 (IL-12p70) \*Concentration in micromol per liter. (mean and standard deviation, median and quartile per groups) | ClinicalTrials.gov |
| Secondary | Connor-Davidson Resilience Rating Scale | Pre-test, Post-test and follow-up (12 months) | The CD-RISC is a 25-item measure of resilience. | ClinicalTrials.gov |
| Secondary | Positive and Negative Affect Schedule (PANAS) | Pre-test, Post-test and follow-up (12 months) | To evaluate positive and negative Affect through two subscales: positive affect - sum negative affect - sum * each question range one to five * higher score - more frequent | ClinicalTrials.gov |
| Other | Five Facet Mindfulness Questionnaire (FFMQ) | Pre-test, Post-test and follow-up (12 months) | To evaluate the mindfulness trace through five subscales: OBSERVING - mean DESCRIBING - mean NONJUDGE - mean NONREACT - mean ATC WITH AWARENESS - mean * each question range one to five * higher score - more mindful | ClinicalTrials.gov |
| Other | Rey Auditory-Verbal Learning Test - RAVLT | Pre-test, Post-test and follow-up (12 months) | To evaluate memory (number of word remember) | ClinicalTrials.gov |
| Other | Stroop test | Pre-test, Post-test and follow-up (12 months) | To evaluate attention and inhibitory behavior (number of errors and time) | ClinicalTrials.gov |
| Other | Digit span test | Pre-test, Post-test and follow-up (12 months) | To evaluate work memory (maximum lenght) | ClinicalTrials.gov |
| Other | Trail Making Test - TMT | Pre-test, Post-test and follow-up (12 months) | To evaluate attention (time to trail every letter or/and number) | ClinicalTrials.gov |
| Other | Hospital Anxiety and Depression Scale (HAADS) | Pre-test, Post-test and follow-up (12 months) | To evaluate anxiety and depression symptoms through two subscales: anxiety - sum depression - sum * each question range zero to four * higher score - more symptons | ClinicalTrials.gov |
| Other | Burnout Clinical Subtypes Questionnaire - BCSQ-12 | Pre-test, Post-test and follow-up (12 months) | To evaluate the burnout clinical subtypes through three subscales: Overload - mean, standard deviation and median Lack of development - mean, standard deviation and median Neglect - mean, standard deviation and median \*each question response range one to seven points Higher scores - More Symptons of Burnout | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 5
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Digit Span Test | Other outcome | ConductCognition |
| Stroop Color-Word Test | Other outcome | ConductCognition |
| Trail Making Test A | Other outcome | ConductCognition |
| Trail Making Test B | Other outcome | ConductCognition |
| Verbal Learning | Other outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)